Location History:
- Dural, AU (2011 - 2016)
- New South Wales, AU (2016 - 2019)
Company Filing History:
Years Active: 2011-2019
Title: Innovator in Pharmacology: The Contributions of Kai Kin Lau
Introduction
Kai Kin Lau, an accomplished inventor based in Dural, Australia, has made significant strides in the field of pharmaceutical science. With a remarkable portfolio featuring four patents, Lau continues to innovate in the development of injectable pharmaceutical compositions.
Latest Patents
Among her notable inventions are two groundbreaking patents focused on injectable pharmaceutical compositions that utilize cyclodextrin, a hydrophobic drug, co-solvents, and preservatives. The first patent details a formulation that comprises water-soluble complexes involving cyclodextrin or its derivatives. This innovative composition not only meets the stringent standards of the European Pharmacopoeia 2011 Test for Efficacy of Antimicrobial Preservation but also adheres to the United States Pharmacopeia 2011 Guidelines for Antimicrobial Effectiveness Testing. The formulation satisfies the criteria required for injectable products, enhancing its applicability in medical scenarios. The second patent mirrors this focus on effective preservation and formulation, further cementing Lau's dedication to pharmaceutical innovation.
Career Highlights
Lau has built her career at Jurox Pty Ltd, where she applies her expertise in developing transformative solutions in pharmacology. Her commitment to innovation has established her as a key figure within the organization, contributing to advancements that improve patient care through effective drug formulation.
Collaborations
Throughout her career, Lau has worked alongside notable colleagues, including Peter John Kieran and Barry Edward Patten. This collaboration fosters a dynamic atmosphere of creativity and knowledge sharing, essential for driving groundbreaking inventions in the pharmaceutical industry.
Conclusion
Kai Kin Lau stands as a prominent inventor in the realm of pharmaceutical innovations. Her contributions significantly impact the efficacy and safety of injectable compositions, which are crucial in medical treatments. As she continues her work at Jurox Pty Ltd, the industry eagerly anticipates her future breakthroughs and advancements.